A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination with Acalabrutinib (ACP-196) in Subjects with Previously Untreated Mantle Cell Lymphoma
A Phase III, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of Zolbetuximab IMAB362 Plus CAPOX Compared with Placebo Plus CAPOX as First-line Treatment of Subjects with Claudin CLDN18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction GEJ Adenocarcinoma
A Multicenter Study of 5-Aminolevulinic Acid 5-ALA to Enhance Visualization of Malignant Tumor in Patients with Newly Diagnosed or Recurrent Malignant Gliomas: A Safety, Histopathology, and Correlative Biomarker Study
A Randomized, Double-blind, Placebo-controlled Phase III Trial of
Pembrolizumab MK-3475 Versus Placebo in Participants with Esophageal Carcinoma
Receiving Concurrent Definitive Chemoradiotherapy KEYNOTE 975
A PHASE 2/3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF NKTR-255 VS PLACEBO FOLLOWING CD19-DIRECTED CAR-T CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA